Blog - medidata

Blog

11 February 2014
Use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products The 'Draft guideline on key aspects for the use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products' has been released for public consultation as of 30 January 2014 with a deadline for comments of 30 July 2014.

08 January 2014
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA)  published a joint three-year work plan outlining key areas of collaboration.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19